About

About Us

Built by rare disease families, for rare disease families

My 2 year old started having 105ºF fevers. We were told he likely had PFAPA, a rare auto inflammatory disease with no existing therapies. Refusing to accept this, we found other patients and families, like Dr. Lina Williamson and Dr. Matt Might, looking to shake up how rare disease therapies are found.

— Josh Resnikoff, CEO

TMA is led by a highly experienced, multicultural team

Joshua Resnikoff

CEO, Cofounder

Entrepreneur and biomedical engineer. Holds several patents in consumer and biotech products. Has an MS BME from Tuft’s University, and helped lead commercial efforts at a Wyss spinout, founded multiple companies, and created a B Corporation that scaled >1000x in its first year.

Martin Grasso

Chief of Enterprise, Cofounder

More than 30 years of experience in structuring and creating enterprise applications based on large datasets. Harvard graduate and President of the Harvard of Alumni Association, 2017.

Jose Fernandez-Alcon

Chief Technical Officer

Software architect with multiple patents, he has dual MSc’s from the Technical University of Madrid and the Eindhoven Technical University. His work includes creating the infrastructure for the DARPA organs-on-chips project at Harvard Med and managing its transition and scale-up at Emulate Bio.

Javier Romero, MD

Chief Medical Officer

Led the application of artificial intelligence to image processing and radiology-based triaging for patients at Mass General. Graduated from Harvard Medical University, has extensive experience leading clinical trials in LATAM for Biopharma.